Refractive Surgery News

Here are some of the top stories of the past week on Healio.com/OSN:

The origin of keratoconus is still hotly debated. Genetic and environmental factors have been widely investigated, as has an inflammatory component.

STAAR Surgical’s Visian Toric Implantable Collamer Lens has been approved by the FDA for the correction of myopia with astigmatism, according to a company press release.

The Refractive Surgery Alliance is creating a new training program for vision correction surgeons that will allow fellows to train at multiple sites, the organization announced in a press release.

The U.S. approval of corneal collagen cross-linking for ectatic disorders provided hope for so many patients with keratoconus, but the real benefit of CXL is if it can be combined with a refractive procedure to give spectacle freedom.

Johnson & Johnson Vision has launched its iDESIGN Refractive Studio, which received FDA approval in June, the company announced in a press release.

Here are some of the week’s top ophthalmology stories:

Compared to manual limbal relaxing incisions performed in conventional phacoemulsification cataract surgery, nonpenetrating femtosecond laser arcuate keratotomy performed during femtosecond laser-assisted cataract surgery can achieve an astigmatic correction of greater magnitude, according to a study.

Good long-term outcomes are difficult to achieve in refractive and cataract surgery patients if ocular surface disease is not effectively managed, according to David Hardten, MD, here at the Twin Cities Ocular Surface Disease Symposium.

Patients with highly myopic eyes who received a trifocal IOL achieved satisfactory refractive and visual outcomes, but the outcomes were not as favorable in eyes with low IOL power compared with higher dioptric IOL power, according to a study.